Cargando…
Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women
A recall for histological pseudocapsule (PS) and reappraisal of transsphenoidal surgery (TSS) as a viable alternative to dopamine agonists in the treatment algorithm of prolactinomas are getting vibrant. We hope to investigate the effectiveness and risks of extra-pseudocapsular transsphenoidal surge...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267792/ https://www.ncbi.nlm.nih.gov/pubmed/35807204 http://dx.doi.org/10.3390/jcm11133920 |
_version_ | 1784743819842945024 |
---|---|
author | Chen, Juan Guo, Xiang Miao, Zhuangzhuang Zhang, Zhuo Liu, Shengwen Wan, Xueyan Shu, Kai Yang, Yan Lei, Ting |
author_facet | Chen, Juan Guo, Xiang Miao, Zhuangzhuang Zhang, Zhuo Liu, Shengwen Wan, Xueyan Shu, Kai Yang, Yan Lei, Ting |
author_sort | Chen, Juan |
collection | PubMed |
description | A recall for histological pseudocapsule (PS) and reappraisal of transsphenoidal surgery (TSS) as a viable alternative to dopamine agonists in the treatment algorithm of prolactinomas are getting vibrant. We hope to investigate the effectiveness and risks of extra-pseudocapsular transsphenoidal surgery (EPTSS) for young women with microprolactinoma, and to look into the factors that influenced remission and recurrence, and thus to figure out the possible indication shift for primary TSS. We proposed a new classification method of microprolactinoma based on the relationship between tumor and pituitary position, which can be divided into hypo-pituitary, para-pituitary and supra-pituitary groups. We retrospectively analyzed 133 patients of women (<50 yr) with microprolactinoma (≤10 mm) who underwent EPTSS in a tertiary center. PS were identified in 113 (84.96%) microadenomas intraoperatively. The long-term surgical cure rate was 88.2%, and the comprehensive remission rate was 95.8% in total. There was no severe or permanent complication, and the surgical morbidity rate was 4.5%. The recurrence rate with over 5 years of follow-up was 9.2%, and a lot lower for the tumors in the complete PS group (0) and hypo-pituitary group (2.1%). Use of the extra-pseudocapsule dissection in microprolactinoma resulted in a good chance of increasing the surgical remission without increasing the risk of CSF leakage or endocrine deficits. First-line EPTSS may offer a greater opportunity of long-term cure for young female patients with microprolactinoma of hypo-pituitary located and Knosp grade 0-II. |
format | Online Article Text |
id | pubmed-9267792 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92677922022-07-09 Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women Chen, Juan Guo, Xiang Miao, Zhuangzhuang Zhang, Zhuo Liu, Shengwen Wan, Xueyan Shu, Kai Yang, Yan Lei, Ting J Clin Med Article A recall for histological pseudocapsule (PS) and reappraisal of transsphenoidal surgery (TSS) as a viable alternative to dopamine agonists in the treatment algorithm of prolactinomas are getting vibrant. We hope to investigate the effectiveness and risks of extra-pseudocapsular transsphenoidal surgery (EPTSS) for young women with microprolactinoma, and to look into the factors that influenced remission and recurrence, and thus to figure out the possible indication shift for primary TSS. We proposed a new classification method of microprolactinoma based on the relationship between tumor and pituitary position, which can be divided into hypo-pituitary, para-pituitary and supra-pituitary groups. We retrospectively analyzed 133 patients of women (<50 yr) with microprolactinoma (≤10 mm) who underwent EPTSS in a tertiary center. PS were identified in 113 (84.96%) microadenomas intraoperatively. The long-term surgical cure rate was 88.2%, and the comprehensive remission rate was 95.8% in total. There was no severe or permanent complication, and the surgical morbidity rate was 4.5%. The recurrence rate with over 5 years of follow-up was 9.2%, and a lot lower for the tumors in the complete PS group (0) and hypo-pituitary group (2.1%). Use of the extra-pseudocapsule dissection in microprolactinoma resulted in a good chance of increasing the surgical remission without increasing the risk of CSF leakage or endocrine deficits. First-line EPTSS may offer a greater opportunity of long-term cure for young female patients with microprolactinoma of hypo-pituitary located and Knosp grade 0-II. MDPI 2022-07-05 /pmc/articles/PMC9267792/ /pubmed/35807204 http://dx.doi.org/10.3390/jcm11133920 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chen, Juan Guo, Xiang Miao, Zhuangzhuang Zhang, Zhuo Liu, Shengwen Wan, Xueyan Shu, Kai Yang, Yan Lei, Ting Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women |
title | Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women |
title_full | Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women |
title_fullStr | Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women |
title_full_unstemmed | Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women |
title_short | Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women |
title_sort | extra-pseudocapsular transsphenoidal surgery for microprolactinoma in women |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267792/ https://www.ncbi.nlm.nih.gov/pubmed/35807204 http://dx.doi.org/10.3390/jcm11133920 |
work_keys_str_mv | AT chenjuan extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT guoxiang extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT miaozhuangzhuang extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT zhangzhuo extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT liushengwen extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT wanxueyan extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT shukai extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT yangyan extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen AT leiting extrapseudocapsulartranssphenoidalsurgeryformicroprolactinomainwomen |